Aztreonam

CAS 78110-38-0 4 current records 4 historicalSmall Molecule

Who holds supplier records for Aztreonam? 4 organisations hold a current record for Aztreonam: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (1) and Netherlands (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Aztreonam: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/aztreonam

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Aztreonam. Country is the organisation's recorded country, not necessarily the manufacturing site.

India1Netherlands1Country not recorded for 2
  • APITORIA PHARMA PRIVATE LTD
    Active DMF 38649 · latest filing Jul 2023
    India Company GMP cert on record
  • CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD
    Active DMF 26856 · latest filing Oct 2013
  • GUANG'AN KINGDAY PHARMA AND CHEM CO LTD
    Active DMF 27508 · latest filing Sept 2013
  • TAPI NL BV
    Active DMF 19342 · latest filing Apr 2006
    Netherlands
Need Aztreonam sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (4)

Organisations whose Type II DMFs for Aztreonam are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • CHONGQING FUAN PHARMACEUTICAL CO LTD
    Inactive DMF 23971 · filed Jul 2010
  • CHANGZHOU FANGYUAN PHARMACEUTICAL CO LTD
    Inactive DMF 20907 · filed Sept 2007
  • ORCHID CHEMICALS AND PHARMACEUTICALS LTD
    Inactive DMF 20014 · filed Dec 2006
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 16751 · filed Aug 2003

Overview

Aztreonam is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL158).

Chemical identity

IUPAC name
2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid
Canonical SMILES
C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2=CSC(=N2)N
InChIKey
WZPBZJONDBGPKJ-VEHQQRBSSA-N
Synonyms
Azactam, Azonam, Aztreon, Aztreonam, Nebactam, NSC-646279, NSC-758913, Primbactam, SO 26776, SQ 26776, SQ-26776, Azthreonam

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Monobactam Antibacterial
Chemical structure
Monobactams

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Aztreonam?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Aztreonam: APITORIA PHARMA PRIVATE LTD (India), CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD, GUANG'AN KINGDAY PHARMA AND CHEM CO LTD and TAPI NL BV (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Aztreonam Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 38649), CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD (DMF 26856), GUANG'AN KINGDAY PHARMA AND CHEM CO LTD (DMF 27508) and TAPI NL BV (DMF 19342). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Aztreonam records mean?

4 organisations have only inactive Type II DMFs for Aztreonam. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Aztreonam supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Aztreonam?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.